Patent details

EP3008071 Title: POLYMORPHIC FORM OF ICOTINIB AND USES THEREOF

Basic Information

Publication number:
EP3008071
PCT Application Number:
CN2014079491
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP148115686
PCT Publication Number:
WO2014198212
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
POLYMORPHIC FORM OF ICOTINIB AND USES THEREOF
French Title of Invention:
FORME POLYMORPHE DE L'ICOTINIB ET SES UTILISATIONS
German Title of Invention:
POLYMORPHE FORM VON ICOTINIB UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
09/06/2014
Grant date:
28/02/2018
EP Publication Date:
20/04/2016
PCT Publication Date:
18/12/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/02/2018
EP B1 Publication Date:
28/02/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/06/2018
Expiration date:
09/06/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/02/2018
 
 

Name:
Betta Pharmaceuticals Co., Ltd
Address:
589, Hongfeng Road, Yuhang Hangzhou, Zhejiang 311100, China (CN)

Inventor

1

Name:
LONG, Wei
Address:
China (CN)

2

Name:
HU, Shaojing
Address:
China (CN)

3

Name:
WANG, Yinxiang
Address:
China (CN)

4

Name:
WANG, Fei
Address:
China (CN)

5

Name:
DING, Lieming
Address:
China (CN)

Priority

Priority Number:
PCT/CN2013/077095
Priority Date:
09/06/2013
Priority Country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC classification:
A61K 31/519; A61P 35/00; C07D 491/056;

Publication

European Patent Bulletin

Issue number:
201809
Publication date:
28/02/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/10/2018 Outgoing Correspondence 1